Monitoring, prophylaxis, and treatment of infections in patients with MM receiving bispecific antibody therapy: consensus recommendations from an expert panel

N Raje, K Anderson, H Einsele, Y Efebera, F Gay… - Blood cancer …, 2023 - nature.com
Bispecific antibodies (BsAbs) are emerging as an important novel class of
immunotherapeutic agents for the treatment of multiple myeloma (MM), and are set to be …

Post-transplant lymphoproliferative disorders

S Gottschalk, CM Rooney, HE Heslop - Annu. Rev. Med., 2005 - annualreviews.org
Post-transplant lymphoproliferative disorder (PTLD) is a life-threatening complication after
hematopoietic stem cell or solid organ transplantation. The majority of PTLD is of B-cell …

Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients

HE Heslop, KS Slobod, MA Pule… - Blood, The Journal …, 2010 - ashpublications.org
T-cell immunotherapy that takes advantage of Epstein-Barr virus (EBV)–stimulated immunity
has the potential to fill an important niche in targeted therapy for EBV-related cancers. To …

The clinical significance of EBV DNA in the plasma and peripheral blood mononuclear cells of patients with or without EBV diseases

JA Kanakry, AM Hegde, CM Durand… - Blood, The Journal …, 2016 - ashpublications.org
Epstein-Barr virus (EBV) is a ubiquitous virus that establishes a latent infection within the
host and in some cases can lead to the development of EBV-associated lymphomas …

Post-transplant lymphoproliferative disorders

VR Dharnidharka, AC Webster, OM Martinez… - Nature reviews Disease …, 2016 - nature.com
Post-transplant lymphoproliferative disorders (PTLDs) are a group of conditions that involve
uncontrolled proliferation of lymphoid cells as a consequence of extrinsic …

Marked increased risk of Epstein-Barr virus-related complications with the addition of antithymocyte globulin to a nonmyeloablative conditioning prior to unrelated …

CG Brunstein, DJ Weisdorf, T DeFor, JN Barker, J Tolar… - Blood, 2006 - ashpublications.org
Umbilical cord blood (UCB) is increasingly used as an alternative source of hematopoietic
stem cells for transplantation for patients who lack a suitable sibling donor. Despite concerns …

Outcome of treatment of Epstein–Barr virus‐related post‐transplant lymphoproliferative disorder in hematopoietic stem cell recipients: a comprehensive review of …

J Styczynski, H Einsele, L Gil… - Transplant infectious …, 2009 - Wiley Online Library
Post‐transplant lymphoproliferative disorder (PTLD) caused by Epstein–Barr virus (EBV) is
an important complication in high‐risk allogeneic hematopoietic stem cell transplant (HSCT) …

Measuring Epstein–Barr virus (EBV) load: the significance and application for each EBV‐associated disease

H Kimura, Y Ito, R Suzuki… - Reviews in medical …, 2008 - Wiley Online Library
Abstract Because Epstein–Barr virus (EBV) is ubiquitous and persists latently in
lymphocytes, simply detecting EBV is insufficient to diagnose EBV‐associated diseases …

Viral infections in HSCT: detection, monitoring, clinical management, and immunologic implications

C Annaloro, F Serpenti, G Saporiti, G Galassi… - Frontiers in …, 2021 - frontiersin.org
In spite of an increasing array of investigations, the relationships between viral infections
and allogeneic hematopoietic stem cell transplantation (HSCT) are still controversial, and …

EBV abortive lytic cycle promotes nasopharyngeal carcinoma progression through recruiting monocytes and regulating their directed differentiation

X Xu, N Zhu, J Zheng, Y Peng, MS Zeng, K Deng… - Plos …, 2024 - journals.plos.org
Epstein-Barr virus (EBV) is associated with several types of human cancer including
nasopharyngeal carcinoma (NPC). The activation of EBV to the lytic cycle has been …